Archive for March, 2011
			
 	  	
			
			
			
				
				
				IRVINGTON, NY — (Marketwire) — 03/02/11 — MELA Sciences (NASDAQ: MELA)  today announced that the company has filed an amendment to the MelaFind®  pre-market approval (PMA) application with the U.S. Food and Drug Administration  (FDA), limiting the indication for use to dermatologists.
“We have clarified the intended use of MelaFind to dermatologists as a  response to public statements made by several dermatologists sitting on the  November 18, 2010 MelaFind FDA review panel,” said Joseph Gulfo, MD, President  and CEO, MELA Sciences. “We look forward to working with the Agency to move the  MelaFind PMA application forward. On a parallel track, we are seeking to obtain  a CE Mark for MelaFind from European regulatory authorities and hope to receive  it in the second half of this year.”
The company also announced that it was recently issued a patent protecting  its methods associated with the quantitative and objective analysis of the  traditional “ABCD” skin characteristics. Asymmetry, Border  irregularity, Color and Diameter are four characteristics used  to identify lesions that require further evaluation by physicians to rule out  melanoma.
Separately, in connection with preparing the company’s proxy materials, board  member Charlie Stiefel advised the company that, for personal reasons, he would  not seek reelection to the board in 2011 and tendered his resignation from the  board. “We would like to extend our gratitude to Charlie for his service. We  sincerely appreciate his counsel and contributions to our organization,” added  Dr. Gulfo.
About MELA Sciences
MELA Sciences is a medical technology company focused on developing  MelaFind®. MelaFind® is a non-invasive and objective multi-spectral computer  vision system designed to aid physicians in the detection of early melanoma from  among clinically atypical (those having one or more clinical or historical  characteristics of melanoma, such as asymmetry, border irregularity, color  variegation, diameter greater than 6 millimeters, evolving, patient concern,  regression, and ugly duckling) cutaneous pigmented lesions that are  non-ulcerated, not bleeding, and less than 2.2 centimeters in diameter, when a  physician chooses to obtain additional information before making a final  decision to biopsy to rule out melanoma.
The MelaFind® Pre-Market Approval (PMA) application was filed with the U.S.  Food and Drug Administration (FDA) in June 2009, received positive FDA Advisory  Panel recommendations in November 2010 and is currently under review at the FDA.  MELA Sciences cannot predict either the timing of the FDA’s decision on the PMA  application or the outcome. FDA approval is required prior to marketing  MelaFind® in the United States.
For more information on MELA Sciences, visit www.melasciences.com.
Safe Harbor 
This press release includes “forward-looking statements” within the meaning  of the Securities Litigation Reform Act of 1995. These statements include but  are not limited to our plans, objectives, expectations and intentions and other  statements that contain words such as “expects,” “contemplates,” “anticipates,”  “plans,” “intends,” “believes” and variations of such words or similar  expressions that predict or indicate future events or trends, or that do not  relate to historical matters. These statements are based on our current beliefs  or expectations and are inherently subject to significant uncertainties and  changes in circumstances, many of which are beyond our control. There can be no  assurance that our beliefs or expectations will be achieved. Actual results may  differ materially from our beliefs or expectations due to economic, business,  competitive, market and regulatory factors.
Add to Digg Bookmark with del.icio.us Add to Newsvine
For further information contact:
For Investors:
David  Carey
Lazar Partners, Ltd.
646-871-8485
For Media:
Hollister  Hovey
Lazar Partners, Ltd.
646-871-8485
				
								
								
				
			
			 
		
			
			
			
				
				
				IRVINE, Calif., March 2, 2011 (GLOBE NEWSWIRE) — Consumer Portfolio  Services, Inc. (Nasdaq:CPSS) (“CPS” or the “Company”) today announced that on  February 24, 2011 it entered into a $100 million two-year warehouse credit line  with UBS Real Estate Securities Inc. Loans under the facility will be secured by  automobile receivables that CPS now holds or will purchase from dealers. The  facility revolves during the first year and amortizes during the second  year.
“This transaction brings our total warehouse capacity to $200 million,” said  Charles E. Bradley, Jr., President and Chief Executive Officer. “With our  expected return to the term securitization market in the next few months, we are  well positioned to meet our contract funding needs.”
About Consumer Portfolio Services, Inc.
Consumer Portfolio Services, Inc. is an independent specialty finance company  that provides indirect automobile financing to individuals with past credit  problems, low incomes or limited credit histories. We purchase retail  installment sales contracts primarily from franchised automobile dealerships  secured by late model used vehicles and, to a lesser extent, new vehicles. We  fund these contract purchases on a long-term basis primarily through the  securitization markets and service the contracts over their lives.
CONTACT:  Investor Relations Contact
          Robert E. Riedl, Chief Investment Officer
          949 753-6800
				
								
								
				
			
			 
		
			
			
			
				
				
				WAKEFIELD, Mass., March 2, 2011 (GLOBE NEWSWIRE) — Edgewater Technology,  Inc. (Nasdaq:EDGW) (www.edgewater.com, “Edgewater” or the “Company”), a  consulting firm that brings a synergistic blend of specialty services to its  clients in the areas of business advisory, analytics, data management and  technology, today announced financial results for its fourth quarter and fiscal  year ended December 31, 2010, which results are preliminary and subject to a  final review as it relates to software product revenue recognition.
Fourth Quarter Results
Preliminary financial results and utilization for the quarter ended  December 31, 2010:
- Total revenue increased 107% to $23.5 million compared to $11.4 million in  the fourth quarter of 2009;
- Service revenue increased 65% to $17.7 million compared to service revenue  of $10.7 million in the fourth quarter of 2009;
- Gross profit was $9.0 million, or 38.0% of total revenue, compared to $4.1  million, or 36.2% of total revenue in the fourth quarter of 2009;
- Gross profit margin related to service revenue was 39.5% compared to 38.4%  in the fourth quarter of 2009;
- Utilization was 75.6% compared to 66.5% for the fourth quarter of 2009;
- Net income (loss) was $675 thousand, or $0.06 per diluted share, compared to  $(1.9) million, or $(0.15) per diluted share, in the fourth quarter of 2009;
- Adjusted EBITDA amounted to $1.5 million, or $0.12 per diluted share,  compared to $(165) thousand, or $(0.01) per diluted share, in the fourth quarter  of 2009; and
- Cash flow provided by operating activities was $1.6 million compared to cash  flow provided by operating activities of $57 thousand during the fourth quarter  of 2009.
Full Year Results
Preliminary financial results and utilization for the fiscal year  ended December 31, 2010:
- Total revenue increased 76.8% to $88.5 million compared to $50.1 million in  fiscal 2009;
- Service revenue increased 49.3% to $68.8 million compared to $46.1 million  in fiscal 2009;
- Gross profit was $32.1 million, or 36.2% of total revenue, compared to $16.1  million, or 32.1% of total revenue in fiscal 2009;
- Gross profit margin related to service revenue was 38.1% compared to 34.5%  in fiscal 2009;
- Utilization was 73.5% compared to 65.5% in fiscal 2009;
- Net loss amounted to $(22.7) million, or $(1.86) per diluted share, compared  to net loss of $(3.8) million, or $(0.32) per diluted share, in fiscal 2009. Our  2010 full year net loss was primarily the result of a third quarter non-cash  charge of $21.9 million in connection with an increase to our previously  established deferred tax valuation allowance;
- Adjusted EBITDA amounted to $3.4 million, or $0.28 per diluted share,  compared to Adjusted EBITDA of $(1.7) million, or $(0.14) per diluted share, in  fiscal 2009; and
- Cash flow provided by operating activities was $698 thousand compared to  cash flow used in operating activities of $(243) thousand in fiscal 2009.
We are issuing these preliminary results because we are in the process of  completing a final review of our software product revenue recognition  procedures. We will issue our final financial results for the fourth quarter and  full year 2010 upon the completion of this review, which will occur before the  filing of our Annual Report on Form 10-K, which is due on March 31, 2011.
The Company acquired Fullscope, Inc. and Meridian Consulting International  (the “Acquired Companies”) on December 31, 2009 and May 17, 2010,  respectively. The operating results associated with the Acquired Companies have  been included in Edgewater’s consolidated operating results since the dates of  the respective acquisitions.
Adjusted EBITDA and Adjusted EBITDA per Diluted Share are Non-GAAP financial  measures. A reconciliation of these measures to their most directly comparable  GAAP measures is included in the financial data accompanying this press  release.
Business Trends; Outlook
“During 2010, Edgewater met several strategic goals that we set, namely:  returning to double-digit organic growth, improving operational performance,  providing positive cash flow and developing our own intellectual property  assets,” stated Shirley Singleton, Edgewater’s Chairman, President and  Chief Executive Officer.
“We are pleased to report improved and/or sustained quarterly operating  metrics on both a sequential and year-over-year basis. The fourth quarter and  overall improvements in our business are directly attributable to the strategic  initiatives we planned in 2009 and executed in 2010. We introduced a new EPM  service offering, added a large Microsoft ERP-centric business and augmented our  custom service offerings with product-based consulting.”
Ms. Singleton continued, “The cumulative effect of these changes is reflected  in our year-over-year growth in total revenue and service revenue, improvement  in our billable consultant utilization rate and improvement in our gross  margin. We look forward to 2011 as a year of continuing growth,” stated Ms.  Singleton.
“Traditionally, we have entered the first quarter with anticipated seasonal  softness in our first quarter sequential service revenues. This has historically  been attributable to our EPM-related service offerings. Entering the first  quarter of 2011, we are not seeing seasonal softness in our EPM-related service  offerings. Based upon this and in consideration of our fourth quarter bid and  proposal activity, we are anticipating first quarter 2011 service revenue to be  up on a sequential basis from the fourth quarter of 2010,” concluded Ms.  Singleton.
Fullscope Embezzlement Update
As previously reported, during the second quarter of 2010 the Company  identified fraudulent activities within its recently acquired Fullscope  Division. We are in the final stages of our investigation of this matter. The  consolidated financial statements as of December 31, 2010 include an estimated  liability accrual of $950 thousand for underpayment of sales and use tax  liabilities in the Fullscope Division during the years 2003 through 2009 and a  corresponding receivable in the same amount. We expect to be able to recover  amounts related to this estimated liability through a fully funded escrow  account as provided for under the indemnification provisions of the Agreement  and Plan of Merger and Reorganization entered into in connection with the  Fullscope acquisition.
Preliminary Fourth Quarter and Full Year Conference Call  Details
Edgewater has scheduled a conference call on Wednesday, March 2, at 10:00  a.m. (ET) to discuss its preliminary fourth quarter and full year 2010 financial  results and other matters. To listen to the call, you can participate by webcast  on Edgewater’s investor relations website at http://ir.edgewater.com or you can  dial 877-713-9347. Investors are advised to dial into the call at least ten  minutes prior to the call to register.
A replay of the call can be accessed via Edgewater’s investor relations  website at http://ir.edgewater.com or by dialing 800-642-1687 (domestic) and  706-645-9291 (international) (pass code 42519083) from 1:00 p.m. ET Wednesday,  March 2 through 11:59 p.m. ET Wednesday, March 16.
About Edgewater
Edgewater is a consulting firm that brings a synergistic blend of specialty  services to its clients in the areas of business advisory, analytics, data  management and technology. We develop business strategies and technology  solutions that address our clients’ specific needs while providing them with an  increased competitive advantage. Headquartered in Wakefield, MA, we typically go  to market both vertically by industry and horizontally by product and technology  specialty and provide our clients with a wide range of business and technology  offerings. To learn more, visit www.edgewater.com or call 800-410-4014.
The Edgewater Technology logo is available at  http://www.globenewswire.com/newsroom/prs/?pkgid=3783
Safe Harbor for Forward-Looking and Cautionary  Statements
This Press Release contains certain forward-looking statements within the  meaning of Section 27A of the Securities Act of 1933, as amended, and Section  21E of the Securities Exchange Act of 1934, as amended, including statements  concerning our expected growth in 2011, the recoverability of funds from  Fullscope escrow, and the expected increase in first quarter 2011 service  revenue on a sequential basis from the fourth quarter of 2010. These  forward-looking statements inherently involve certain risks and uncertainties,  although they are based on our current plans or assessments which are believed  to be reasonable as of the date of this Press Release. Factors that may cause  actual results, goals, targets or objectives to differ materially from those  contemplated, projected, forecasted, estimated, anticipated, planned or budgeted  in such forward-looking statements include, among others, the following  possibilities: (1) failure to obtain new customers or retain significant  existing customers; (2) the loss of one or more key executives and/or employees;  (3) changes in industry trends, such as a decline in the demand for Business  Intelligence (“BI”) and Enterprise Performance Management (“EPM”) solutions,  custom development and system integration services and/or declines in  industry-wide information technology (“IT”) spending, whether on a temporary or  permanent basis and/or delays by customers in initiating new projects or  existing project milestones; (4) inability to execute upon growth objectives,  including new services and growth in entities acquired by our Company; (5)  adverse developments and volatility involving economic, geopolitical or  technology market conditions; (6) unanticipated events or the occurrence of  fluctuations or variability in the matters identified under “Critical Accounting  Policies;” (7) delays in, or the failure of, our sales pipeline being converted  to billable work and recorded as revenue; (8) inability to recruit and retain  professionals with the high level of information technology skills and  experience needed to provide our services; (9) failure to expand outsourcing  services to generate additional revenue; (10) any changes in ownership of the  Company or otherwise that would result in a limitation of the net operating loss  carry forward under applicable tax laws; (11) the failure of the marketplace to  embrace specialty consulting services; and/or (12) failure to make a successful  claim against the Fullscope escrow account. In evaluating these statements, you  should specifically consider various factors described above as well as the  risks outlined under Item I “Business – Factors Affecting Finances, Business  Prospects and Stock Volatility” in our 2009 Annual Report on Form 10-K filed  with the SEC on March 15, 2010. These factors may cause our actual results to  differ materially from those contemplated, projected, anticipated, planned or  budgeted in any such forward-looking statements.
Although we believe that the expectations in the forward-looking statements  are reasonable, we cannot guarantee future results, levels of activity,  performance, growth, earnings per share or achievements. However, neither we nor  any other person assumes responsibility for the accuracy and completeness of  such statements. Except as required by law, we undertake no obligation to update  any of the forward-looking statements after the date of this Press Release to  conform such statements to actual results.
Selected Financial Data:
| EDGEWATER TECHNOLOGY,  INC. | 
| Preliminary Condensed Consolidated  Statement of Operations | 
| (In thousands, except per share  amounts) | 
| (Unaudited) | 
|  | 
|  | Three Months  Ended | Twelve Months  Ended | 
|  | December 31, | December 31, | 
|  | 2010 | 2009 | 2010 | 2009 | 
| Revenue: |  |  |  |  | 
| Service revenue | $17,680 | $10,699 | $68,843 | $46,120 | 
| Software | 3,632 | 47 | 11,508 | 664 | 
| Royalty revenue | 700 | – | 2,341 | – | 
| Reimbursable expenses | 1,524 | 645 | 5,853 | 3,301 | 
| Total revenue | 23,536 | 11,391 | 88,545 | 50,085 | 
|  |  |  |  |  | 
| Cost of revenue: |  |  |  |  | 
| Project and personnel costs | 10,695 | 6,590 | 42,640 | 30,190 | 
| Software costs | 2,363 | 32 | 7,977 | 496 | 
| Reimbursable expenses | 1,524 | 645 | 5,853 | 3,301 | 
| Total cost of revenue | 14,582 | 7,267 | 56,470 | 33,987 | 
| Gross profit | 8,954 | 4,124 | 32,075 | 16,098 | 
|  |  |  |  |  | 
| Selling, general and administrative | 7,299 | 4,876 | 29,313 | 18,412 | 
| Depreciation and amortization | 1,012 | 602 | 4,023 | 2,694 | 
| Operating income (loss) | 643 | (1,354) | (1,261) | (5,008) | 
|  |  |  |  |  | 
| Interest income and other, net | 12 | 17 | 34 | 122 | 
| Income (loss) before income taxes | 655 | (1,337) | (1,227) | (4,886) | 
|  |  |  |  |  | 
| Income tax (benefit) provision | (20) | 521 | 21,513 | (1,047) | 
| Net income (loss) | $675 | $(1,858) | $(22,740) | $(3,839) | 
|  |  |  |  |  | 
| BASIC INCOME (LOSS) PER SHARE: |  |  |  |  | 
| Basic income (loss) per share | $0.06 | $(0.15) | $(1.86) | $(0.32) | 
| Weighted average shares outstanding –  Basic | 12,282 | 12,055 | 12,195 | 12,067 | 
|  |  |  |  |  | 
| DILUTED INCOME (LOSS) PER SHARE: |  |  |  |  | 
| Diluted income (loss) per share | $0.06 | $(0.15) | $(1.86) | $(0.32) | 
| Weighted average shares outstanding –  Diluted | 12,296 | 12,055 | 12,195 | 12,067 | 
|  | 
|  | 
| EDGEWATER TECHNOLOGY,  INC. | 
| Preliminary Condensed Consolidated  Balance Sheets | 
| (In thousands) | 
| (Unaudited) | 
|  | 
|  | December 31, | 
|  | 2010 | 2009 | 
| Assets |  |  | 
| Cash and marketable securities | $10,903 | $12,661 | 
| Restricted cash | – | 702 | 
| Accounts receivable, net | 19,496 | 18,081 | 
| Deferred taxes, current | – | 348 | 
| Prepaid expenses and other assets, current | 1,985 | 1,639 | 
| Total current assets | 32,384 | 33,431 | 
| Fixed assets, net | 2,797 | 3,297 | 
| Deferred taxes, net | – | 20,760 | 
| Goodwill and intangible assets, net | 15,870 | 16,225 | 
| Other assets | 175 | 93 | 
| Total Assets | $51,226 | $73,806 | 
|  |  |  | 
| Liabilities and Stockholders’ Equity |  |  | 
| Accounts payable and accrued liabilities | $7,137 | $10,642 | 
| Accrued contingent earnout consideration | 2,800 | 1,200 | 
| Accrued payroll and related liabilities | 5,336 | 4,051 | 
| Deferred revenue and other liabilities | 1,939 | 2,270 | 
| Capital lease obligations, current | 148 | 220 | 
| Total current liabilities | 17,360 | 18,383 | 
| Capital lease obligations | 52 | 200 | 
| Other long term liabilities | 15 | 107 | 
| Total liabilities | 17,427 | 18,690 | 
| Stockholders’ Equity | 33,799 | 55,116 | 
| Total Liabilities and Stockholders’  Equity | $51,226 | $73,806 | 
|  |  |  | 
| Shares Outstanding | 12,342 | 12,132 | 
Non-GAAP Financial Measures
Edgewater reports its financial results in accordance with generally accepted  accounting principles (“GAAP”). Management believes, however, that certain  non-GAAP financial measures used in managing the Company’s business may provide  users of this financial information with additional meaningful comparisons  between current results and prior reported results. Certain of the information  set forth herein and certain of the information presented by the Company from  time to time may constitute non-GAAP financial measures within the meaning of  Regulation G adopted by the Securities and Exchange Commission. We have  presented herein a reconciliation of these measures to the most directly  comparable GAAP financial measure. The non-GAAP measures presented herein may  not be comparable to similarly titled measures presented by other companies. As  noted in the footnote below, the foregoing measures have limitations and do not  serve as a substitute and should not be construed as a substitute for GAAP  performance, but provide supplemental information concerning our performance  that our investors and we find useful.
Edgewater views Adjusted EBITDA and Adjusted EBITDA per Diluted Share as  important indicators of performance, consistent with the manner in which  management measures and forecasts the Company’s performance. We believe Adjusted  EBITDA measures are important performance metrics because they facilitate the  analysis of our results, exclusive of certain non-cash items, including items  which do not directly correlate to our existing business, providing specialty IT  services. For instance, the exit of our former significant unrelated operations  in 2000 and 2001 created significant net operating loss carry-forwards and  deferred tax assets, and the tax provisions that we take under GAAP, for which  there is no corresponding federal tax payment obligation for us, and the  adjustments that we make to our deferred tax asset, based on the prospects and  anticipated future profitability of our ongoing operations, can be significant  and can obscure, either significantly, or in part, period-to-period changes in  our core operating results. Likewise, we incur direct transaction costs related  to acquisitions which are expensed in our GAAP financial statements. Our  Adjusted EBITDA calculation excludes the effects of direct acquisition-related  costs to facilitate an understanding of comparative period-to-period changes in  our core operating results. Similarly, we incurred, and have excluded from our  Adjusted EBITDA calculation, costs associated with the Fullscope Embezzlement  Issue as we believe that the non-recurring nature of the costs associated with  this issue makes comparison of our current and historical financial results  difficult.
We believe that Adjusted EBITDA metrics provide qualitative insight into our  current performance; we use these measures to evaluate our results, the  performance of our management team and our management’s entitlement to incentive  compensation; and we believe that making this information available to investors  enables them to view our performance the way that we view our performance and  thereby gain a meaningful understanding of our core operating results, in  general, and from period to period.
|  | 
|  | 
| EDGEWATER TECHNOLOGY,  INC. | 
| Reconciliation of Preliminary GAAP Net  Income (Loss) to Non-GAAP Adjusted EBITDA | 
| (In Thousands, except per share  amounts) | 
| (Unaudited) | 
|  | 
|   | For The Three Months  Ended December 31, | For The Twelve Months  Ended December 31, | 
|  | 2010 | 2009 | 2010 | 2009 | 
| Preliminary Reported GAAP net income (loss) | $  675 | $ (1,858) | $ (22,740) | $(3,839) | 
| Add: Income tax (benefit) expense | (20) | 521 | 21,513 | (1,047) | 
| Add: Depreciation and amortization | 1,012 | 602 | 4,023 | 2,694 | 
| Add: Direct Acquisition costs | 2 | 587 | 451 | 617 | 
| Add: Fullscope embezzlement costs | (175) | – | 187 | – | 
| Less: Interest income and other, net | (12) | (17) | (34) | (122) | 
| Adjusted EBITDA1 | $ 1,482 | $ (165) | $ 3,400 | $ (1,697) | 
| Adjusted EBITDA per diluted share1 | $ 0.12 | $ (0.01) | $ 0.28 | $ (0.14) | 
| Adjusted EBITDA as a percentage of total  revenue1 | 6.3% | (1.4)% | 3.8% | (3.4)% | 
|  |  |  |  |  | 
1- Adjusted EBITDA, Adjusted EBITDA Per Diluted Share and Adjusted EBITDA as  a Percentage of Total Revenue are Non-GAAP performance measures and are not  intended to be performance measures that should be regarded as an alternative  to, or more meaningful than, either GAAP Operating Income, GAAP Net Income and  Diluted Earnings Per Share. Adjusted EBITDA and Adjusted EBITDA per Diluted  Share measures presented may not be comparable to similarly titled measures  presented by other companies. Adjusted EBITDA is defined as net income less  interest income and other, net, plus taxes, depreciation and amortization,  goodwill impairment charges, direct acquisition costs and the Fullscope  Embezzlement Issue costs. Adjusted EBITDA per Diluted Share is defined as  Adjusted EBITDA divided by the diluted common shares outstanding used in Diluted  Earnings per Share calculations.
CONTACT: Timothy R. Oakes, Chief Financial Officer
         Russell Smith, Senior Vice President / Investor Relations
         (781) 246-3343
         ir@edgewater.com
				
								
								
				
			
			 
		
			
			
			
				
				
				Mar. 1, 2011 (Business Wire) — Mad Catz® Interactive, Inc. (“Mad  Catz” or “the Company”) (AMEX/TSX: MCZ), a leading third-party interactive  entertainment accessory provider, and Electronic Arts Inc. (NASDAQ: ERTS), a  leading global interactive entertainment software company, announced today an  agreement to produce branded PC and console videogame accessories based on  ‘The Sims™’ franchise. The agreement grants Mad Catz non-exclusive rights  to produce and market a wide range of videogame accessories for PC, Microsoft®  Xbox 360® video game and entertainment system, Sony®  PlayStation® 3 computer entertainment system, Wii™, Nintendo DS™ and  Nintendo 3DS™ systems.
Commenting on the agreement, Darren Richardson, President and Chief Executive  Officer of Mad Catz, “We are excited to work with EA and one of the most popular  gaming franchises of all time. The Sims is a new and exciting opportunity  for Mad Catz to reach a wider audience that includes both casual and enthusiast  gamers. Our agreement with EA is part of our long-term strategy of working with  the premium gaming brands and deliver innovative consumer focused accessories.”
“We are delighted to be working with Mad Catz to further broaden the appeal  of The Sims franchise through the introduction of specialty PC and  console accessories,” said Patrick O’Brien, Vice President of Electronic  Arts. “Mad Catz has a long history of working with game publishers to deliver  unique products, and we believe that together we can introduce a range of  accessories that appeal to players of The Sims series.”
About Mad Catz Interactive, Inc.
Mad Catz is a leading global provider of innovative products for the  interactive entertainment industry. Mad Catz develops and markets accessories  for videogame systems and PCs under its Mad Catz (casual gaming), Saitek  (simulation), Cyborg (pro gaming), Eclipse (home and office) and Tritton (gaming  audio) brands. Mad Catz also operates e-commerce and content websites for  videogame and PC products under its GameShark brand, develops, manufactures and  markets proprietary earphones under its AirDrives brand, and publishes and  distributes video/PC games. Mad Catz distributes its products through most of  the leading retailers offering interactive entertainment products and has  offices in North America, Europe and Asia. For additional information please go  to www.madcatz.com, as well as www.store.gameshark.com, www.saitek.com,  www.cyborggaming.com, www.eclipsetouch.com, www.trittontechnologies.com,  www.gameshark.com and www.airdrives.com.
| Track Mad Catz via the following social media: | 
| Facebook® Page: |  | http://www.facebook.com/MadCatzInc | 
| Twitter® Page: |  | http://twitter.com/MadCatzInc | 
| YouTube® Channel: |  | http://www.youtube.com/MadCatzCompany | 
About The Sims
The Sims™ franchise, the groundbreaking game series that allows  players to create and live a virtual, simulated life on a computer, celebrates  its ten year anniversary in 2010 with an impressive more than 125 million units  sold since its launch in February 2000. Now translated into 22 different  languages and available in 60 different countries, The Sims series has  quickly become a universal gaming and cultural phenomenon. Since its June 2009  launch, The Sims 3 has sold more than 10 million copies worldwide to date  and was the #1 best-selling PC title for 2009 in North America and Europe. Fan  intensity is evidenced through nearly 250 million downloads of player created  content including: The Sims characters, houses, stories and more. The Sims  3 community site, www.thesims3.com, welcomes up to seven million unique  visitors monthly, handles more than 240 content downloads every minute and more  than 3.5 million uploads have been made to date, including 11 movies each hour.  The Sims 3 YouTube Channel is within the top 10 most viewed sponsored  channels of all time with more than 45 million video views. Visit The Sims  3 official website to see what the players are creating at www.TheSims3.com  or the official YouTube Channel for The Sims at  http://www.youtube.com/user/TheSims. The Sims 3 is currently available  for PC, Mac, iPhone®, iPod touch® and mobile devices. The Sims 3 is also  available on the PlayStation®3 computer entertainment system, Xbox 360®  videogame and entertainment system, Nintendo DS™, and Wii™ and in March 2011 on  the Nintendo 3DS.
| Follow The Sims social media: | 
| Facebook® Page: |  | http://www.facebook.com/TheSims3 | 
| Twitter® Page: |  | http://twitter.com/TheSims3 | 
| YouTube® Channel: |  | http://www.youtube.com/TheSims | 
About Electronic Arts
Electronic Arts Inc. (EA), headquartered in Redwood City, California, is a  leading global interactive entertainment software company. Founded in 1982, the  Company develops, publishes, and distributes interactive software worldwide for  video game systems, personal computers, wireless devices and the Internet.  Electronic Arts markets its products under four brand names: EA SPORTS™, EA™, EA  Mobile™ and POGO™. In fiscal 2010, EA posted GAAP net revenue of $3.7 billion  and had 27 titles that sold more than one million units. EA’s homepage and  online game site is www.ea.com. More information about EA’s products and full  text of press releases can be found on the Internet at http://info.ea.com.
EA, EA SPORTS, EA Mobile, POGO and The Sims are trademarks of Electronic Arts  Inc. “PlayStation” is a registered trademark of Sony Computer Entertainment Inc.  Microsoft, Xbox and Xbox 360 are trademarks of the Microsoft group of companies.  Wii, Nintendo DS and Nintendo 3DS are trademarks of Nintendo. iPhone and iPod  touch are trademarks of Apple inc., registered in the U.S. and other countries.  All other trademarks are the property of their respective owners.
Mad Catz Safe Harbor for Forward Looking Statements:
This press release contains forward-looking statements about the Company’s  business prospects that involve substantial risks and uncertainties. The Company  assumes no obligation to update the forward-looking statements contained in this  press release as a result of new information or future events or developments.  You can identify these statements by the fact that they use words such as  “anticipate,” “estimate,” “expect,” “project,” “intend,” “should,” “plan,”  “goal,” “believe,” and other words and terms of similar meaning in connection  with any discussion of future operating or financial performance. Among the  factors that could cause actual results to differ materially are the following:  the ability to maintain or renew the Company’s licenses; competitive  developments affecting the Company’s current products; first party price  reductions; the ability to successfully market both new and existing products  domestically and internationally; difficulties or delays in manufacturing; or a  downturn in the market or industry. A further list and description of these  risks, uncertainties and other matters can be found in the Company’s reports  filed with the Securities and Exchange Commission and the Canadian Securities  Administrators.

Media:
Mad Catz Interactive,  Inc.
Alex Verrey, Global PR & Communications Manager
+44  (0) 1908 336 538
averrey@madcatz.com
or
Mad Catz Interactive,  Inc.
Michael Greco, Vice President of  Marketing
+1-619-321-3564
mgreco@madcatz.com
or
Investors:
Mad Catz Interactive,  Inc.
Allyson Vanderford, Interim Chief Financial  Officer
+1-619-321 3545
avanderford@madcatz.com
or
Jaffoni and  Collins Incorporated
Joseph Jaffoni, Norberto Aja and Jim  Leahy
212-835-8500
mcz@jcir.com
				
								
								
				
			
			 
		
			
			
			
				
				
				VANCOUVER, BRITISH COLUMBIA — (Marketwire) — 02/01/11 — Endeavour Silver  Corp. (TSX: EDR)(NYSE Amex: EXK)(DBFrankfurt: EJD) released today its review of  exploration results in 2010 and its exploration plans for 2011. The Company’s  exploration drilling programs in Mexico met with continued success in 2010,  highlighted by the discovery of new, high grade silver-gold mineralized zones  near Endeavour’s two silver mining operations, Guanacevi Mines in Durango State,  and Guanajuato Mines in Guanajuato State.
Barry Devlin, Vice President of Exploration, commented, “Last year, our  talented exploration team once again delivered some exciting new silver-gold  vein discoveries which will be included in our next NI 43-101 reserve/resource  estimate expected in a few weeks time. Endeavour drilled approximately 41,400  meters (136,000 feet) in 148 drill holes testing multiple exploration targets in  five separate mining districts in order to make new discoveries and expand  silver resources.”
“At Guanacevi, our focus last year moved north into the San Pedro area, where  we received encouraging sample and drill results from a number of recently  discovered mineralized zones on historic mine properties. Two exciting new  finds, Epsilon and La Blanca, are in the vicinity of historic high grade silver  mines along the western side of San Pedro, and two more, San Joachin and Santa  Isabel, lie along strike to the north of historic high grade silver mines that  occupy the east-bounding faults of the Guanacevi horst block (Endeavour’s Santa  Cruz, Porvenir Norte, Porvenir Dos and Porvenir Cuatro mines are all located  along the west-bounding fault of the Guanacevi horst block).”
“At Guanajuato, we enjoyed significant exploration success in 2010 extending  high grade silver-gold mineralization within the Lucero vein for more than 800  meters along strike and more importantly, Endeavour discovered three new  mineralized veins parallel to and in the footwall of Lucero, the Karina,  Fernanda and Daniela veins. Two drill rigs are working full time to extend these  mineralized zones and several compelling new vein targets will also be drilled  this year. As a result, Endeavour has commenced a major expansion of the  Guanajuato plant to 1000 tonnes per day in the 3rd Quarter, 2011.”
Guanacevi District
Endeavour currently holds 100% interests in 1,072 hectares (2,649 acres)  within the historic silver district of Guanacevi which produced over 450 million  ounces (oz) of silver according to SGM, the Mexican Geological Service. Since  acquiring Guanacevi in 2004, Endeavour has found five high-grade silver  ore-bodies along a five kilometer (3 mile) length of the prolific Santa Cruz  silver vein (see Guanacevi maps on website,  http://www.edrsilver.com/s/Guanacevi.asp).
In 2010, Endeavour drilled 7,000 meters in 23 holes in the San Pedro area  resulting in two exciting new finds, Epsilon and La Blanca. Recent drill results  not previously announced include 3,319 grams per tonne (gpt) silver and 7.1 gpt  gold over a 2.0 meter (m) true width in the Epsilon area (hole EPS1-2), and  3,000 gpt silver and 7.7 gpt gold over a 2.1 m true width in the La Blanca area  (hole BC-03).
Endeavour continued to expand its land position at Guanacevi in 2010 with the  addition of the 3 properties totaling 25 hectares. Many of the old silver mining  properties in Guanacevi had histories of small high grade mine production but  very few of them were ever systematically explored and drilled.
Previously unreleased highlights of the 2010 drilling programs at Guanacevi  were as follows:
--------------------------------------------------------------------------
San Pedro (Epsilon-Soto)
--------------------------------------------------------------------------
                                        Core      True
                              From    Length     Width     Silver     Gold
Hole        Vein                (m)       (m)       (m)      (gpt)    (gpt)
--------------------------------------------------------------------------
EPS1-2      Manto           223.90      2.50      1.96      3,319     7.06
            --------------------------------------------------------------
            Including       223.90      0.35      0.27    greater    31.80
                                                             than
                                                           10,000
--------------------------------------------------------------------------
EPS2-2      Soto            235.45      1.35      1.33        214     0.41
            --------------------------------------------------------------
            Including       235.45      0.30      0.30        917     1.67
--------------------------------------------------------------------------
EPS3-1      Epsilon         249.50      1.15      0.58      6,680    11.17
            --------------------------------------------------------------
            Soto            280.60      1.05      0.86        351     0.70
--------------------------------------------------------------------------
EPS3-3      Soto            296.25      4.10      3.72        406     0.64
            --------------------------------------------------------------
            Including       297.55      0.55      0.50        937     1.57
--------------------------------------------------------------------------
--------------------------------------------------------------------------
San Pedro (La Blanca-Mi Nina)
--------------------------------------------------------------------------
                                        Core      True
                              From    Length     Width     Silver     Gold
Hole        Vein                (m)       (m)       (m)      (gpt)    (gpt)
--------------------------------------------------------------------------
BC-01       Blanca            45.9      5.55      1.87        348     0.28
            --------------------------------------------------------------
            Including         48.8      0.35      0.12      1,165     less
                                                                      than
                                                                      0.05
--------------------------------------------------------------------------
BC-03       Blanca           33.95      3.50      2.11      3,000     7.66
            --------------------------------------------------------------
            Including        36.15      0.65      0.39    greater    37.00
                                                             than
                                                           10,000
--------------------------------------------------------------------------
--------------------------------------------------------------------------
Porvenir Norte
--------------------------------------------------------------------------
                                        Core      True
                              From    Length     Width     Silver     Gold
Hole        Vein                (m)       (m)       (m)      (gpt)    (gpt)
--------------------------------------------------------------------------
PS-618-01   Z1               433.5     11.90     10.69      274.7     0.75
--------------------------------------------------------------------------
PS-628-01   Z2              455.00      3.15      2.63      420.6     2.01
--------------------------------------------------------------------------
PS-636-01   Z2              438.50      1.81      1.62      330.4     0.47
            --------------------------------------------------------------
            Z1              482.35      4.15      2.28      316.8     0.46
--------------------------------------------------------------------------
PS-636-03   Z2N             429.69      2.61      2.49    1,919.3     6.43
            --------------------------------------------------------------
            Z1              435.28      2.41      2.29      597.1     0.92
--------------------------------------------------------------------------
Guanajuato District
Endeavour currently holds 100% interests in 2,314 hectares (5,719 acres)  within the historic silver district of Guanajuato which produced over 1.2  billion oz silver according to the SGM. Since acquiring Guanajuato in 2007,  Endeavour has discovered three high-grade silver-gold ore-bodies, one along the  Veta Madre ore-bearing structure northwest of the Cebada mine and two along the  La Luz mineralized veins southeast of the Lucero/Bolanitos mine (see Guanajuato  maps on website, http://www.edrsilver.com/s/BolanitosMine.asp).
In 2010, Endeavour drilled 18,000 meters in 61 holes in the Lucero area  resulting in three exciting new finds, Karina, Fernanda and Daniela. Recent  drill results not previously announced include 158 gpt silver and 6.7 gpt gold  over an 8.1 m true width in the Daniela vein (hole KA-27), and 367 gpt silver  and 1.9 gpt gold over a 1.8 m true width in the Karina vein (hole KA-29).
Like Guanacevi, Endeavour continued to expand its land position at Guanajuato  in 2010 with the addition of the 4 properties totaling 243 hectares. Many of the  old silver mining properties in Guanajuato also had histories of small high  grade mine production but few of them were systematically explored and drilled.
Previously unreleased highlights of the 2010 drilling programs at Guanajuato  were as follows:
--------------------------------------------------------------------------
Karina-Fernanda-Daniela Drill Results
--------------------------------------------------------------------------
                                        Core      True
                              From    Length     Width     Silver     Gold
Hole        Vein                (m)       (m)       (m)      (gpt)    (gpt)
--------------------------------------------------------------------------
KA-25       Karina           77.60      1.20      1.04        286     1.22
            --------------------------------------------------------------
            Fernanda        115.90      1.60      1.20        140     3.57
            --------------------------------------------------------------
            Vein            151.25      1.35      0.87        428     6.72
--------------------------------------------------------------------------
KA-26       Vein            126.45      0.75      0.57        287     0.80
            --------------------------------------------------------------
            Daniela         160.15      6.75      3.14        110     4.57
            --------------------------------------------------------------
            Vein            174.35      0.95      0.77         91     8.22
--------------------------------------------------------------------------
KA-27       Vein            133.30      0.60      0.49        204     5.00
            --------------------------------------------------------------
            Vein            205.80      0.90      0.69        313     5.00
            --------------------------------------------------------------
            Vein            210.05      0.50      0.43        383     5.50
            --------------------------------------------------------------
            Daniela         238.45     21.10      8.08        158     6.73
            --------------------------------------------------------------
            Including       256.75      2.80      1.05        471    11.98
            --------------------------------------------------------------
            Vein            267.55      3.40      1.34         64     7.98
--------------------------------------------------------------------------
KA-29       Karina           76.45      2.20      1.80        367     1.88
            --------------------------------------------------------------
            Vein             81.80      0.75      0.48         21    10.50
            --------------------------------------------------------------
            Fernanda        119.30      1.05      0.78        189     4.80
--------------------------------------------------------------------------
--------------------------------------------------------------------------
Bolanitos, Cebada
--------------------------------------------------------------------------
                                        Core      True
                              From    Length     Width     Silver     Gold
Hole        Vein                (m)       (m)       (m)      (gpt)    (gpt)
--------------------------------------------------------------------------
BVU 11      Bolanitos       348.20      2.40      2.08        116     0.93
--------------------------------------------------------------------------
BVU 12      Bolanitos       421.87      1.63      1.15        519     0.51
--------------------------------------------------------------------------
CVU 01      Cecilia          80.20      0.85      0.80        165      1.7
--------------------------------------------------------------------------
CVU 03      Cecilia          87.25      1.75      1.64        191     2.16
--------------------------------------------------------------------------
CVU 04      Cecilia          72.10      0.80      0.75        372     0.83
--------------------------------------------------------------------------
SJU 11FW    San Jose        283.20      0.20      0.18      1,195     1.41
            --------------------------------------------------------------
            San Jose        297.75      1.90      1.72        749     0.91
--------------------------------------------------------------------------
CU-18       Veta Madre      108.00      1.00      0.80      1,190     0.85
--------------------------------------------------------------------------
Parral and Arroyo Seco Properties
In 2010, Endeavour drilled 10,000 meters in 34 holes at the San Juanico  property in order to extend the known silver-gold-lead-zinc mineralization on  Endeavour’s adjacent El Cometa property. Both properties are located within the  historic silver district of Parral, Chihuahua, which produced more than 250  million oz silver according to the SGM.
As of March 2009, Endeavour reported an NI 43-101 indicated resource at  Cometa of 1.5 million oz silver and inferred resources totaling 1.0 million oz  plus significant gold, lead and zinc resources (see Parral maps on website,  http://www.edrsilver.com/s/ParralMine.asp). An updated combined resource  estimate is anticipated for El Cometa and San Juanico shortly.
Recent drill results not previously announced include 52 gpt silver, 0.7 gpt  gold, 4.2% lead and 1.9% zinc over an 4.8 m true width in the Cometa vein (hole  SJ0-2), and 267 gpt silver, 1.2 gpt gold, 0.4% lead and 0.4% zinc over a 2.0 m  true width also in the Cometa vein (hole SJ1-1). Once the resource estimate is  completed, management will review the economic mining potential of the Parral  project.
An additional 1200 meters of drilling in 12 holes was carried out at  Endeavour’s 1,215 hectare (3,002 acre) Arroyo Seco project in Michoacan to try  and extend the previously discovered manto-style silver-lead-zinc mineralization  along strike and down dip.
Recent drill results not previously announced include 864 gpt silver and  0.82% lead over an 1.1 m true width in hole AS-14, and 311 gpt silver and 0.94%  copper over a 2.0 m true width in hole AS-13. Management has decided to seek a  partner or buyer for the Arroyo Seco properties as they do not have sufficient  silver potential to be of interest to Endeavour.
2011 Exploration Plans
In 2011, Endeavour plans an aggressive $9.2 million, 47,000 meter, 175-hole  exploration drill program to test multiple exploration targets within three of  the mining districts where Endeavour is currently active in Mexico plus any new  targets within new districts the Company may acquire during the year.
The first priorities will be to follow up the new discoveries made near  Endeavour’s two mining operations at Guanacevi and Guanajuato as highlighted  above and to test several new prospective targets within those two districts.  Management is confident that the potential to discover and develop new  silver-gold resources at both Guanacevi and Guanajuato remains high.
Endeavour will also commence surface exploration drilling on the San  Sebastian properties acquired last year in Jalisco state, Mexico. Surface  sampling has identified numerous high-grade silver and gold mineralized zones at  San Sebastian that will be tested in 2011.
Significant sample results are as follows:
SIGNIFICANT SAN SEBASTIAN SAMPLE RESULTS
----------------------------------------------------------------------
                              Width       Ag       Au       Pb      Zn
Sample ID       Zone             (m)    (gpt)    (gpt)    (ppm)   (ppm)
----------------------------------------------------------------------
ESA 10014       Los Pollos     Grab    1,185     0.74    1,370     355
----------------------------------------------------------------------
ESA 10027       La Obra        1.15    1,120     1.06      547     124
----------------------------------------------------------------------
ESA 10037       Ocote Alto     0.80      821     0.69      371      98
----------------------------------------------------------------------
ESA 10045       San Martin     0.30      364     1.23    1,130     734
----------------------------------------------------------------------
ESA 10058       La Obra        0.40      370     0.13       71      86
----------------------------------------------------------------------
ESA 10060       Guadalupe      0.35      647     2.51       34     105
----------------------------------------------------------------------
ESA 10066       La Obra        1.00      548     0.38      631     281
----------------------------------------------------------------------
ESA 10069       La Obra        0.20      429     0.07      724     535
----------------------------------------------------------------------
ESA 10075       El Tajo        Grab    1,295     2.82   11,150     500
----------------------------------------------------------------------
ESA 10076       El Porvenir    Grab    5,040    18.80    4,920   4,610
----------------------------------------------------------------------
ESA 10089       El Culebro     Grab      534     1.94    1,160      63
----------------------------------------------------------------------
ESA 10096       El Tajo        0.55      673     0.64   18,800     227
----------------------------------------------------------------------
ESA 10098       El Tajo        0.50      581     1.16   13,200   5,240
----------------------------------------------------------------------
ESA 10099       El Tajo        0.56    1,295     2.02   25,100   3,630
----------------------------------------------------------------------
ESA 10903       El Tajo        1.50      414     0.37      897     293
----------------------------------------------------------------------
ESA 10904       El Tajo        1.50      474     0.78      449     366
----------------------------------------------------------------------
ESA 10907       San Agustin    0.50      603     0.23    2,050   1,755
----------------------------------------------------------------------
ESA 10912       El Rosario     0.30      634     0.68      740     164
----------------------------------------------------------------------
ESA 10926La     Carbonera      Grab    4,010    14.75   11,800     743
----------------------------------------------------------------------
Barry Devlin, M.Sc., P.Geo. Vice President, Exploration is the Qualified  Person who reviewed this news release and supervised the surface drilling and  sampling programs at the Parral, Guanacevi and Guanajuato Projects. Godfrey  Walton, M.Sc. P.Geo. President and Chief Operating Officer is the Qualified  Person who reviewed this news release and supervised the mine surface and  underground drilling programs at the Guanacevi and Guanajuato Mines. A Quality  Control sampling program of reference standards, blanks and duplicates has been  instituted to monitor the integrity of all assay results. All core samples are  split at the Parral, Guanajuato, or Guanacevi field offices and shipped to  ALS-Chemex Labs, where they are dried, crushed, split and 50 gram pulp samples  are prepared for analysis. Gold and silver are determined by fire assay with an  atomic absorption (AA) finish and lead, zinc and copper are determined by AA.
Endeavour Silver Corp. is a mid-cap silver mining company focused on the  growth of its silver production, reserves and resources in Mexico. Since  start-up in 2004, Endeavour has posted six consecutive years of growing silver  production, reserves and resources. The organic expansion programs now underway  at Endeavour’s two operating silver mines in Mexico combined with its strategic  acquisition and exploration programs should help Endeavour achieve its goal to  become the next premier mid-tier silver mining company.
ENDEAVOUR SILVER CORP.
Bradford Cooke, Chairman and CEO
CAUTIONARY DISCLAIMER – FORWARD LOOKING STATEMENTS
This news release contains “forward-looking statements” within the meaning of  the United States private securities litigation reform act of 1995 and  “forward-looking information” within the meaning of applicable Canadian  securities legislation. Such forward-looking statements and information herein  include, but are not limited to, statements regarding Endeavour’s anticipated  future performance, including silver and gold production, timing and  expenditures to develop new silver mines and mineralized zones, silver and gold  grades and recoveries, cash costs per ounce, capital expenditures and sustaining  capital and the use of proceeds from the Company’s recent financing. The Company  does not intend to, and does not assume any obligation to update such  forward-looking statements or information, other than as required by applicable  law. Forward-looking statements or information involve known and unknown risks,  uncertainties and other factors that may cause the actual results, level of  activity, performance or achievements of Endeavour and its operations to be  materially different from those expressed or implied by such statements.
Such factors include, among others: fluctuations in the prices of silver and  gold, fluctuations in the currency markets (particularly the Mexican peso,  Canadian dollar and U.S. dollar); changes in national and local governments,  legislation, taxation, controls, regulations and political or economic  developments in Canada and Mexico; operating or technical difficulties in  mineral exploration, development and mining activities; risks and hazards of  mineral exploration, development and mining (including environmental hazards,  industrial accidents, unusual or unexpected geological conditions, pressures,  cave-ins and flooding); inadequate insurance, or inability to obtain insurance;  availability of and costs associated with mining inputs and labour; the  speculative nature of mineral exploration and development, diminishing  quantities or grades of mineral reserves as properties are mined; the ability to  successfully integrate acquisitions; risks in obtaining necessary licenses and  permits, and challenges to the company’s title to properties; as well as those  factors described in the section “risk factors” contained in the Company’s most  recent form 40F/Annual Information Form filed with the S.E.C. and Canadian  securities regulatory authorities. Although the Company has attempted to  identify important factors that could cause actual results to differ materially  from those contained in forward-looking statements or information, there may be  other factors that cause results to be materially different from those  anticipated, described, estimated, assessed or intended. There can be no  assurance that any forward-looking statements or information will prove to be  accurate as actual results and future events could differ materially from those  anticipated in such statements or information. Accordingly, readers should not  place undue reliance on forward-looking statements or information.
The TSX Exchange has neither approved nor disapproved the contents of this  news release.
Contacts:
Endeavour Silver Corp.
Hugh Clarke
Toll free: 877-685-9775  or (604) 685-9775
(604) 685-9744  (FAX)
hugh@edrsilver.com
www.edrsilver.com
				
								
								
				
			
			 
		
			
			
			
				
				
				Mar. 1, 2011 (Business Wire) — Accelr8 Technology Corporation (NYSE  Amex: AXK) announced that one of its outside principal investigators received  acceptance to present results of a new study in Europe. Researchers from the  Washington University in St. Louis School of Medicine (the Barnes-Jewish  Hospital) will present at the 21st annual ECCMID to be held May 7-10,  2011 in Milan, Italy. ECCMID is the European Congress of Clinical Microbiology  and Infectious Disease, www.eccmid-icc2011.org. It is a major international  meeting for professionals in clinical microbiology and Infectious Diseases  Medicine.
The study will describe alternative new tests, including Accelr8’s BACcel™  rapid diagnostic system, to identify an important new type of antibiotic  resistance expressed by “Staph” bacteria. Standard culturing methods are unable  to detect this new type of resistance, abbreviated as “hVISA.”
Staph often causes simple infections, but also causes life-threatening  hospital-acquired infections. “MRSA” is the type of broadly drug resistant,  dangerous Staph strain frequently cited in news stories as a “superbug.”  Physicians most often prescribe vancomycin if they suspect that a MRSA strain  causes an infection. Staph variants have now emerged with declining vancomycin  susceptibility. hVISA strains appear to be susceptible in standard culturing  tests, but careful analysis in specialized research labs reveals important  differences that indicate possible resistance. Since vancomycin is the  cornerstone drug for suspected MRSA, hVISA may present a serious new threat.
Unlike other methods, the BACcel™ system eliminates the need for prior  culturing, thereby reporting results on the same day rather than the 2-3 days  required by culturing methods. The new BACcel™ test for hVISA joins tests for  other resistance types intended to be performed at the same time on the same  patient specimen.
According to David Howson, Accelr8’s president, “The new presentation gives  the large international community a close look at the BACcel™ system concept and  its performance. The new test may help investigators perform more definitive  clinical studies to assess the spread of this emerging new threat,” Howson  concluded.
About Accelr8
Accelr8 Technology Corporation (www.accelr8.com) is a developer of innovative  materials and instrumentation for advanced applications in medical  instrumentation, basic research, drug discovery, and bio-detection. Accelr8 is  developing a rapid analytical platform for infectious pathogens, the BACcel™  system, based on its innovative surface coatings, assay processing, and  detection technologies. In addition, Accelr8 licenses certain of its proprietary  technology for use in applications outside of Accelr8’s own products.
Certain statements in this news release may be “forward-looking statements”  within the meaning of Section 27A of the Securities Act of 1933, as amended, and  Section 21E of the Securities Exchange Act of 1934, as amended. Statements  regarding future prospects and developments are based upon current expectations  and involve certain risks and uncertainties that could cause actual results and  developments to differ materially from the forward-looking statement, including  those detailed in the company’s filings with the Securities and Exchange  Commission. Accelr8 does not undertake an obligation to publicly update or  revise any forward-looking statements, whether as a result of new information or  future events.

Accelr8 Technology Corp.
Tom Geimer, +1-303-863-8088
tom.geimer@accelr8.com
or
Metzger  Associates
John Metzger, +1-303-786-7000, ext. 2202
john@metzger.com
				
								
								
				
			
			 
		
			
			
			
				
				
				
ROCKVILLE, Md., March 1, 2011 /PRNewswire/ — Novavax, Inc. (Nasdaq: NVAX)  announced today an agreement to license its proprietary, recombinant  virus-like-particle (VLP) vaccine technology to LG Life Sciences, Ltd. (LGLS).  Under the agreement, LGLS receives an exclusive license to manufacture, develop  and commercialize influenza vaccines using Novavax’s recombinant VLP technology  in South Korea. LGLS also receives a non-exclusive license to manufacture,  develop and commercialize influenza VLP vaccines in certain emerging market  countries.
LGLS will be responsible for funding clinical development and licensure of  influenza VLP vaccines in South Korea and other countries, and for construction  of a new VLP vaccine manufacturing facility planned at LGLS’s Osong campus in  South Korea.  Novavax will receive upfront and milestone payments from LGLS in  addition to double-digit royalty rate payments from commercial sales. Novavax  will provide VLP technology transfer and manufacturing support for LGLS’s new  vaccine production facility.
Dr. Rahul Singhvi, CEO and President of Novavax, stated: “LGLS is an  affiliate of LG, a global conglomerate. LGLS is a leading provider of vaccines  to supranational health organizations such as UNICEF and the Pan American Health  Organization (PAHO). We welcome this opportunity to develop a recombinant  influenza vaccine solution for South Korea and other countries served by LGLS.   This new partnership with LGLS is further validation of our VLP technology and,  as we have done previously with our joint venture in India with Cadila  Pharmaceuticals, further expands our development efforts into new territories.  LGLS will help us advance our technology in Korea and other countries,  consistent with our commercial strategy of developing regional partnerships and  in-country manufacturing solutions with leading pharmaceutical companies around  the world.”
Dr. Iljae Jung, CEO and President of LGLS, commented: “We look forward to  working closely with Novavax in advancing the VLP influenza vaccines for people  around the world.  We anticipate that Novavax and LGLS together will make  significant achievements in the field of influenza vaccines with our technology,  expertise and combined resources.”
About LG Life Sciences, Ltd.
LG Life Sciences, Ltd. (LGLS), an LG affiliate, is a leading pharmaceutical  company headquartered in South Korea.  LGLS is committed to developing a leading  portfolio of drugs that prevent, treat and cure diseases across a broad range of  therapeutic areas, including medicines to fight various infectious diseases, and  improving the health and quality of life of patients around the world.   For  additional information, please visit www.lgls.com.
About Novavax 
Novavax, Inc. (Nasdaq: NVAX), a clinical-stage biopharmaceutical company,  employs its cutting-edge technology to create next-generation vaccines to  prevent serious infectious diseases, such as pandemic and seasonal influenza and  respiratory syncytial virus (RSV). The company’s proprietary virus-like  particles (VLPs) technology and single-use bioprocessing system enables rapid  vaccine development and production where and when it’s needed, worldwide. The  company has formed a joint venture with Cadila Pharmaceuticals, named CPL  Biologicals, to develop and manufacture vaccines, biological therapeutics and  diagnostics in India. Additional information about Novavax is available on the  company’s website: www.novavax.com.
Forward Looking Statements 
Statements herein relating to the licensure by LGLS of Novavax’s  recombinant influenza vaccine technology and other future financial or business  performance or matters are forward-looking statements within the meaning of the  Private Securities Litigation Reform Act. Novavax and LGLS caution that these  forward-looking statements are subject to numerous assumptions, risks and  uncertainties, which change over time. Factors that may cause actual results to  differ materially from the results discussed in the forward-looking statements  include: neither Novavax nor LGLS have yet manufactured, or relied on third  parties to manufacture, any recombinant vaccines at a commercial scale;  historical and current results may not be predictive of future trial results for  influenza vaccines; further testing is required before regulatory approval can  be applied for and regulatory agencies may not approve a vaccine even if the  results are similar or better than the results reported to date; there are  uncertainties related to the initiation, enrollment, progress and completion of  clinical trials; production of a vaccine could depend on many factors outside  Novavax’s or its licensee’s control. Further information on the factors and  risks that could affect Novavax’s business, financial conditions and results of  operations, is contained in Novavax’s filings with the U.S. Securities and  Exchange Commission, which are available at www.sec.gov. These forward-looking  statements speak only as of the date of this press release, and neither Novavax  nor LGLS assume a duty to update forward-looking statements.
SOURCE Novavax, Inc.